aluates Reports

$ 0.0

Automative

Global Immuno-Oncology Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-20U9090

Global Immuno Oncology Market Size Status and Forecast 2022

BUY CHAPTERS

Global Immuno-Oncology Market Research Report 2024

Code: QYRE-Auto-20U9090

Report

February 2024

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bristol–Myers Squibb

Merck& Co. Inc

Roche

Astrazeneca plc

Sanofi

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc

Merck KGaA

Immuno-Oncology Market Size

The global Immuno-Oncology market was valued at US$ 43650 million in 2023 and is anticipated to reach US$ 116680 million by 2030, witnessing a CAGR of 14.9% during the forecast period 2024-2030.

Immuno-Oncology Market

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.

This report aims to provide a comprehensive presentation of the global market for Immuno-Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Oncology.

Report Scope

The Immuno-Oncology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immuno-Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immuno-Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immuno-Oncology Market Report

Report Metric	Details
Report Name	Immuno-Oncology Market
Accounted market size in 2023	US$ 43650 million
Forecasted market size in 2030	US$ 116680 million
CAGR	14.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Immune Checkpoint Inhibitors Cytokine-Based Immunotherapy Cancer Vaccines CAR-T Cell Therapy Others
Segment by Application	Hospitals Drugstores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-Oncology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Immuno-Oncology Market growing?

Ans: The Immuno-Oncology Market witnessing a CAGR of 14.9% during the forecast period 2024-2030.

What is the Immuno-Oncology Market size in 2030?

Ans: The Immuno-Oncology Market size in 2030 will be US$ 116680 million.

Who are the main players in the Immuno-Oncology Market report?

Ans: The main players in the Immuno-Oncology Market are Bristol-Myers Squibb, Merck & Co., Inc., Roche AG, AstraZeneca, Plc, Sanofi S.A., Dendreon Pharmaceuticals, Novartis, Gilead Sciences Inc., Merck KGaA

What are the Application segmentation covered in the Immuno-Oncology Market report?

Ans: The Applications covered in the Immuno-Oncology Market report are Hospitals, Drugstores, Others

What are the Type segmentation covered in the Immuno-Oncology Market report?

Ans: The Types covered in the Immuno-Oncology Market report are Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immune Checkpoint Inhibitors

1.2.3 Cytokine-Based Immunotherapy

1.2.4 Cancer Vaccines

1.2.5 CAR-T Cell Therapy

1.2.6 Others

1.3 Market by Application

1.3.1 Global Immuno-Oncology Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Drugstores

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immuno-Oncology Market Perspective (2019-2030)

2.2 Immuno-Oncology Growth Trends by Region

2.2.1 Global Immuno-Oncology Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Immuno-Oncology Historic Market Size by Region (2019-2024)

2.2.3 Immuno-Oncology Forecasted Market Size by Region (2025-2030)

2.3 Immuno-Oncology Market Dynamics

2.3.1 Immuno-Oncology Industry Trends

2.3.2 Immuno-Oncology Market Drivers

2.3.3 Immuno-Oncology Market Challenges

2.3.4 Immuno-Oncology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immuno-Oncology Players by Revenue

3.1.1 Global Top Immuno-Oncology Players by Revenue (2019-2024)

3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2019-2024)

3.2 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Immuno-Oncology Revenue

3.4 Global Immuno-Oncology Market Concentration Ratio

3.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2023

3.5 Immuno-Oncology Key Players Head office and Area Served

3.6 Key Players Immuno-Oncology Product Solution and Service

3.7 Date of Enter into Immuno-Oncology Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Immuno-Oncology Breakdown Data by Type

4.1 Global Immuno-Oncology Historic Market Size by Type (2019-2024)

4.2 Global Immuno-Oncology Forecasted Market Size by Type (2025-2030)

5 Immuno-Oncology Breakdown Data by Application

5.1 Global Immuno-Oncology Historic Market Size by Application (2019-2024)

5.2 Global Immuno-Oncology Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Immuno-Oncology Market Size (2019-2030)

6.2 North America Immuno-Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Immuno-Oncology Market Size by Country (2019-2024)

6.4 North America Immuno-Oncology Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immuno-Oncology Market Size (2019-2030)

7.2 Europe Immuno-Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Immuno-Oncology Market Size by Country (2019-2024)

7.4 Europe Immuno-Oncology Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immuno-Oncology Market Size (2019-2030)

8.2 Asia-Pacific Immuno-Oncology Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Immuno-Oncology Market Size by Region (2019-2024)

8.4 Asia-Pacific Immuno-Oncology Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immuno-Oncology Market Size (2019-2030)

9.2 Latin America Immuno-Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Immuno-Oncology Market Size by Country (2019-2024)

9.4 Latin America Immuno-Oncology Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immuno-Oncology Market Size (2019-2030)

10.2 Middle East & Africa Immuno-Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Immuno-Oncology Market Size by Country (2019-2024)

10.4 Middle East & Africa Immuno-Oncology Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Bristol-Myers Squibb

11.1.1 Bristol-Myers Squibb Company Detail

11.1.2 Bristol-Myers Squibb Business Overview

11.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction

11.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2019-2024)

11.1.5 Bristol-Myers Squibb Recent Development

11.2 Merck & Co., Inc.

11.2.1 Merck & Co., Inc. Company Detail

11.2.2 Merck & Co., Inc. Business Overview

11.2.3 Merck & Co., Inc. Immuno-Oncology Introduction

11.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2019-2024)

11.2.5 Merck & Co., Inc. Recent Development

11.3 Roche AG

11.3.1 Roche AG Company Detail

11.3.2 Roche AG Business Overview

11.3.3 Roche AG Immuno-Oncology Introduction

11.3.4 Roche AG Revenue in Immuno-Oncology Business (2019-2024)

11.3.5 Roche AG Recent Development

11.4 AstraZeneca, Plc

11.4.1 AstraZeneca, Plc Company Detail

11.4.2 AstraZeneca, Plc Business Overview

11.4.3 AstraZeneca, Plc Immuno-Oncology Introduction

11.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2019-2024)

11.4.5 AstraZeneca, Plc Recent Development

11.5 Sanofi S.A.

11.5.1 Sanofi S.A. Company Detail

11.5.2 Sanofi S.A. Business Overview

11.5.3 Sanofi S.A. Immuno-Oncology Introduction

11.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2019-2024)

11.5.5 Sanofi S.A. Recent Development

11.6 Dendreon Pharmaceuticals

11.6.1 Dendreon Pharmaceuticals Company Detail

11.6.2 Dendreon Pharmaceuticals Business Overview

11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction

11.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2019-2024)

11.6.5 Dendreon Pharmaceuticals Recent Development

11.7 Novartis

11.7.1 Novartis Company Detail

11.7.2 Novartis Business Overview

11.7.3 Novartis Immuno-Oncology Introduction

11.7.4 Novartis Revenue in Immuno-Oncology Business (2019-2024)

11.7.5 Novartis Recent Development

11.8 Gilead Sciences Inc.

11.8.1 Gilead Sciences Inc. Company Detail

11.8.2 Gilead Sciences Inc. Business Overview

11.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction

11.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2019-2024)

11.8.5 Gilead Sciences Inc. Recent Development

11.9 Merck KGaA

11.9.1 Merck KGaA Company Detail

11.9.2 Merck KGaA Business Overview

11.9.3 Merck KGaA Immuno-Oncology Introduction

11.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2019-2024)

11.9.5 Merck KGaA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Bristol–Myers Squibb

Merck& Co. Inc

Roche

Astrazeneca plc

Sanofi

Dendreon Pharmaceuticals

Novartis

Gilead Sciences Inc

Merck KGaA

List of Tables

Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immune Checkpoint Inhibitors

Table 3. Key Players of Cytokine-Based Immunotherapy

Table 4. Key Players of Cancer Vaccines

Table 5. Key Players of CAR-T Cell Therapy

Table 6. Key Players of Others

Table 7. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Immuno-Oncology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Immuno-Oncology Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Immuno-Oncology Market Share by Region (2019-2024)

Table 11. Global Immuno-Oncology Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Immuno-Oncology Market Share by Region (2025-2030)

Table 13. Immuno-Oncology Market Trends

Table 14. Immuno-Oncology Market Drivers

Table 15. Immuno-Oncology Market Challenges

Table 16. Immuno-Oncology Market Restraints

Table 17. Global Immuno-Oncology Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Immuno-Oncology Market Share by Players (2019-2024)

Table 19. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2023)

Table 20. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Immuno-Oncology Product Solution and Service

Table 24. Date of Enter into Immuno-Oncology Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Immuno-Oncology Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Immuno-Oncology Revenue Market Share by Type (2019-2024)

Table 28. Global Immuno-Oncology Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Immuno-Oncology Revenue Market Share by Type (2025-2030)

Table 30. Global Immuno-Oncology Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Immuno-Oncology Revenue Market Share by Application (2019-2024)

Table 32. Global Immuno-Oncology Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Immuno-Oncology Revenue Market Share by Application (2025-2030)

Table 34. North America Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Immuno-Oncology Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Immuno-Oncology Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Immuno-Oncology Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Immuno-Oncology Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Immuno-Oncology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Immuno-Oncology Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Immuno-Oncology Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Immuno-Oncology Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Immuno-Oncology Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Immuno-Oncology Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Immuno-Oncology Market Size by Country (2025-2030) & (US$ Million)

Table 49. Bristol-Myers Squibb Company Detail

Table 50. Bristol-Myers Squibb Business Overview

Table 51. Bristol-Myers Squibb Immuno-Oncology Product

Table 52. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 53. Bristol-Myers Squibb Recent Development

Table 54. Merck & Co., Inc. Company Detail

Table 55. Merck & Co., Inc. Business Overview

Table 56. Merck & Co., Inc. Immuno-Oncology Product

Table 57. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 58. Merck & Co., Inc. Recent Development

Table 59. Roche AG Company Detail

Table 60. Roche AG Business Overview

Table 61. Roche AG Immuno-Oncology Product

Table 62. Roche AG Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 63. Roche AG Recent Development

Table 64. AstraZeneca, Plc Company Detail

Table 65. AstraZeneca, Plc Business Overview

Table 66. AstraZeneca, Plc Immuno-Oncology Product

Table 67. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 68. AstraZeneca, Plc Recent Development

Table 69. Sanofi S.A. Company Detail

Table 70. Sanofi S.A. Business Overview

Table 71. Sanofi S.A. Immuno-Oncology Product

Table 72. Sanofi S.A. Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 73. Sanofi S.A. Recent Development

Table 74. Dendreon Pharmaceuticals Company Detail

Table 75. Dendreon Pharmaceuticals Business Overview

Table 76. Dendreon Pharmaceuticals Immuno-Oncology Product

Table 77. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 78. Dendreon Pharmaceuticals Recent Development

Table 79. Novartis Company Detail

Table 80. Novartis Business Overview

Table 81. Novartis Immuno-Oncology Product

Table 82. Novartis Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 83. Novartis Recent Development

Table 84. Gilead Sciences Inc. Company Detail

Table 85. Gilead Sciences Inc. Business Overview

Table 86. Gilead Sciences Inc. Immuno-Oncology Product

Table 87. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 88. Gilead Sciences Inc. Recent Development

Table 89. Merck KGaA Company Detail

Table 90. Merck KGaA Business Overview

Table 91. Merck KGaA Immuno-Oncology Product

Table 92. Merck KGaA Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)

Table 93. Merck KGaA Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Immuno-Oncology Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Immuno-Oncology Market Share by Type: 2023 VS 2030

Figure 3. Immune Checkpoint Inhibitors Features

Figure 4. Cytokine-Based Immunotherapy Features

Figure 5. Cancer Vaccines Features

Figure 6. CAR-T Cell Therapy Features

Figure 7. Others Features

Figure 8. Global Immuno-Oncology Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Immuno-Oncology Market Share by Application: 2023 VS 2030

Figure 10. Hospitals Case Studies

Figure 11. Drugstores Case Studies

Figure 12. Others Case Studies

Figure 13. Immuno-Oncology Report Years Considered

Figure 14. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Immuno-Oncology Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Immuno-Oncology Market Share by Region: 2023 VS 2030

Figure 17. Global Immuno-Oncology Market Share by Players in 2023

Figure 18. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2023

Figure 20. North America Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Immuno-Oncology Market Share by Country (2019-2030)

Figure 22. United States Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Immuno-Oncology Market Share by Country (2019-2030)

Figure 26. Germany Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Immuno-Oncology Market Share by Region (2019-2030)

Figure 34. China Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Immuno-Oncology Market Share by Country (2019-2030)

Figure 42. Mexico Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Immuno-Oncology Market Share by Country (2019-2030)

Figure 46. Turkey Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 49. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 50. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 51. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 52. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 53. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 55. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 56. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Nocturia Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39M10215

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Medicine Treat BPH Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33F12613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Neurorehabilitation Gaming Systems Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E10017

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

Global Addison's Disease Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-15W2944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions